Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA Registry

VDZ achieved clinical response of active EIMs in nearly one-third of patients after 3 months. Although infrequent, VDZ may exacerbate inactive EIMs and induce de novo EIMs during therapy, potentially leading to treatment discontinuation.

Authors

Institutions

Publication Details

Journal
Journal of Crohn s and Colitis
Published
2026-03-01
DOI
https://doi.org/10.1093/ecco-jcc/jjag024
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA Registry

Marta Quiñones Calvo, Pablo Pérez-Galindo, P Vega, Olga Merino et al.
Journal of Crohn s and Colitis
Inflammatory Bowel Disease
article

Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA Registry

Marta Quiñones Calvo, Pablo Pérez-Galindo, P Vega, Olga Merino, Daniel Carpio, Federico Bertoletti, Pedro Almela, Rufo Lorente, M Vela, Saioa de la Maza, Marta Mo Carrillo-Palau, Juan Ángel Ferrer, Alejandra Utrilla, Andrés Castaño, Alicia Algaba, María Chaparro, Manuel Barreiro-de Acosta, María González-Vivó, Javier P Gisbert, Jordina Llaó, Eugeni Domènech, Ramón Pajares, the ENEIDA Registry of GETECCU, Lucía Madero-Velázquez
article en

Abstract

VDZ achieved clinical response of active EIMs in nearly one-third of patients after 3 months. Although infrequent, VDZ may exacerbate inactive EIMs and induce de novo EIMs during therapy, potentially leading to treatment discontinuation.

Journal of Crohn s and ColitisVol. 20(3)
Hospital Universitario de Canarias (ES), Hospital de Sant Pau (ES), Hospital Universitario Nuestra Señora de Candelaria (ES), Althaia (ES), Hospital de Basurto (ES), Complejo Hospitalario Universitario de Santiago (ES), Hospital Universitario Fundación Alcorcón (ES), Hospital Universitario Puerta de Hierro Majadahonda (ES), Hospital General Universitario de Ciudad Real (ES), Hospital General Universitari de Castelló (ES), Hospital Del Mar (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Hospital Universitario Central de Asturias (ES), Hospital de Cruces (ES), Hospital Universitario de Fuenlabrada (ES), Hospital Universitari Germans Trias i Pujol (ES), Hospital General San Jorge (ES), Complejo Hospitalario de Pontevedra (ES), Hospital Universitario Infanta Sofía (ES), Complejo Hospitalario de Ourense (ES), Universidad Autónoma de Madrid (ES)
Openalex Percentile: Top 7%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.